Drug Enforcement D-0391-2025

cGMP Deviations

Status

Ongoing

Classification

Class II

Report Date

May 7, 2025

Termination Date

—

Product Information

Product description
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.
Product quantity
1190 Bottles
Reason for recall
cGMP Deviations
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide in the US

Location & Firm

Recalling firm
Preferred Pharmaceuticals, Inc.
Address
1250 N Lakeview Ave Ste O, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0391-2025
Event ID
96756
Recall initiation date
April 18, 2025
Center classification date
April 28, 2025
Code info
Lot #: L0224T, K1824M, K0124N, J1624V, J0824O, I2424E, I1024O, A0925F, L2324L, Exp: 7/31/2026.
More code info
—